Monocyte Differentiation Service from iPSC

Reference the resources below for more information about the product/service or contact us today to learn more.
Catalog # :
Format :
  • Description
  • Related Products

Monocyte Differentiation Service Details

iPSC-derived monocytes refer to a type of white blood cell that is generated through the use of induced pluripotent stem cells (iPSCs) that have been differentiated into monocytes.

Monocytes are a critical component of the immune system and play a key role in defending the body against pathogens, such as bacteria and viruses. Dysfunction of monocytes has been implicated in a range of inflammatory and autoimmune disorders, such as rheumatoid arthritis and multiple sclerosis.

The use of iPSCs to generate monocytes provides researchers with a valuable tool for studying the development and function of these cells, as well as for developing new treatments for immune-related disorders. iPSC-derived monocytes can also be used for drug screening and toxicity testing, as they provide a reliable and reproducible source of human cells that are difficult to obtain from traditional sources.

Overall, iPSC-derived monocytes have the potential to advance our understanding of the complex processes underlying immune function and dysfunction, and may ultimately lead to the development of new treatments for a range of inflammatory and autoimmune disorders.

  • Standard - CD14, CD16, and CD11b Biomarkers
  • Fully Customizable Service - Inquire

Standard Packaging:

  • Ship 1-2 million iPS cells (1-2 cryovials; 1 million cells/vial); OR
    • With pathogen and SARS-CoV-2 test results
      • Optional Pathogen Testing Service is available
  • Select one of our Control iPS Cell Lines; OR
  • Let ASC generate your iPSCs from your human or non-human samples

Standard Deliverables:

  • 2 million differentiated cells 
  • Data & Report
    • Biomarkers used to identify the monocytes: CD14, CD16, CD11b

Turnaround Time: 2 months

Please contact us for details and quotes.